enVVeno Medical (NVNO) Depreciation and Depletion (2018 - 2025)
enVVeno Medical's (NVNO) quarterly Depreciation and Depletion came in at $100000.0 in Q1 2025, little changed year-on-year from $100000.0 in Q1 2024, and little changed quarter-over-quarter from $100000.0 in Q1 2024.
enVVeno Medical (NVNO) Depreciation and Depletion (2018 - 2025) Analysis & Trends
enVVeno Medical's Depreciation and Depletion history runs 8 years deep, the most recent figure standing at $100000.0 for Q1 2025.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $100000.0 in Q1 2025; TTM through Mar 2025 was $400000.0, a 12.38% increase from a year earlier, with the FY2025 full-year figure at $100000.0, down 50.0% from the prior year.
- Depreciation and Depletion steadied at $100000.0 in Q1 2025 per NVNO's latest filing, from $100000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $100000.0 in Q1 2021 and bottomed at -$40942.0 in Q2 2021.
- The 5-year median for Depreciation and Depletion is $100000.0 (2021), against an average of $62500.0.
- Biggest YoY gain for Depreciation and Depletion was 408.23% in 2021; the steepest drop was 261.92% in 2021.
- Year by year, Depreciation and Depletion stood at $55924.0 in 2021, then jumped by 78.81% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Per Business Quant, the three latest NVNO Depreciation and Depletion figures stand at $100000.0 (Q1 2025), $100000.0 (Q1 2024), and $100000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 55,924.00 |
| Dec 31, 2021 | 55,924.00 |
| Sep 30, 2021 | -14,982.00 |
| Sep 30, 2021 | -14,982.00 |
| Jun 30, 2021 | -40,942.00 |
| Jun 30, 2021 | -40,942.00 |
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 33,143.00 |
| Dec 31, 2020 | 33,143.00 |
| Sep 30, 2020 | 21,896.00 |
| Sep 30, 2020 | 21,896.00 |